Fang-Yi Su
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 8
- Advancements in Transdermal Drug Delivery 2
-
- Lipid Membrane Structure and Behavior 3
- RNA Interference and Gene Delivery 2
- Co-authors
- Hsing‐Wen Sung (9 shared papers)Er‐Yuan Chuang (9 shared papers)Kun‐Ju Lin (8 shared papers)Tzu‐Chen Yen (6 shared papers)Kiran Sonaje (3 shared papers)Michael T. Tseng (2 shared papers)Shiaw‐Pyng Wey (4 shared papers)Yi‐Cheng Ho (3 shared papers)
- Journals
- Biomaterials (6 papers)Nanomedicine Nanotechnology Biology and Medicine (2 papers)Journal of Controlled Release (2 papers)Molecular Pharmaceutics (1 paper)American Journal Of Pathology (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Fang-Yi Su
13 papers receiving 956 citations
Peers
Comparison fields: 5 of 97
- Pharmaceutical Science 509
- Biomaterials 231
- Molecular Medicine 48
- Molecular Biology 346
- Endocrinology, Diabetes and Metabolism 66
Countries citing papers authored by Fang-Yi Su
This map shows the geographic impact of Fang-Yi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang-Yi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang-Yi Su more than expected).
Fields of papers citing papers by Fang-Yi Su
This network shows the impact of papers produced by Fang-Yi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang-Yi Su. The network helps show where Fang-Yi Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Fang-Yi Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 216 | |
| 2 | 2012 | 183 | |
| 3 | 2011 | 131 | |
| 4 | 2013 | 89 | |
| 5 | 2012 | 80 | |
| 6 | 2012 | 65 | |
| 7 | 2013 | 52 | |
| 8 | 2018 | 48 | |
| 9 | 2013 | 46 | |
| 10 | 2016 | 25 | |
| 11 | 2019 | 22 | |
| 12 | 2014 | 14 | |
| 13 | 2016 | 1 |
About Fang-Yi Su
Fang-Yi Su is a scholar working on Pharmaceutical Science, Molecular Biology, Biomaterials, Pulmonary and Respiratory Medicine and Organic Chemistry, having authored 13 papers that have together received 972 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (8 papers), Nanoparticle-Based Drug Delivery (4 papers), Lipid Membrane Structure and Behavior (3 papers), Inhalation and Respiratory Drug Delivery (2 papers), RNA Interference and Gene Delivery (2 papers), Advancements in Transdermal Drug Delivery (2 papers), Diabetes Management and Research (1 paper) and Amyotrophic Lateral Sclerosis Research (1 paper). The work is most often cited by research in Pharmaceutical Science (509 citations), Biomaterials (231 citations), Molecular Medicine (48 citations), Molecular Biology (346 citations) and Endocrinology, Diabetes and Metabolism (66 citations). Fang-Yi Su has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Hsing‐Wen Sung, Er‐Yuan Chuang, Kun‐Ju Lin, Tzu‐Chen Yen, Kiran Sonaje, Michael T. Tseng, Shiaw‐Pyng Wey, Yi‐Cheng Ho, Chiung-Tong Chen and Barnali Maiti. Their work appears in journals such as Biomaterials, Nanomedicine Nanotechnology Biology and Medicine, Journal of Controlled Release, Molecular Pharmaceutics and American Journal Of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.